(EUNY) iShares Emerging Market - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B652H904 • Global Emerging Markets Equity
EUNY: Stocks, Bonds, Emerging Markets, Dividend, Equity
The iShares Emerging Market Dividend UCITS ETF (EUNY), listed on XETRA, is designed to track the performance of the Morningstar EM TME NR USD Index. This ETF focuses on dividend-paying equities in emerging markets, offering exposure to companies with a history of distributing dividends. The fund is managed by BlackRock and provides diversification across various emerging market economies. EUNY is structured as a UCITS-compliant ETF, adhering to European regulatory standards for transparency and investor protection. It is suited for investors seeking both growth and income opportunities in emerging markets.
From a technical standpoint, EUNY has shown a moderate trading volume, with an average of 48,783 shares traded over the past 20 days. The ETF is currently priced at 14.45 EUR, slightly below its 20-day moving average of 14.53 but above its 50-day moving average of 14.27. The 200-day moving average stands at 13.74, indicating a gradual upward trend over the longer term. The Average True Range (ATR) of 0.15 reflects relatively low volatility in recent trading sessions.
In terms of fundamental analysis, EUNY manages a substantial asset base of 565.86 million EUR, underscoring its liquidity and investor confidence. The ETFs focus on dividend-paying stocks in emerging markets positions it as a vehicle for capturing yield in regions with higher growth potential compared to developed markets. The Morningstar EM TME NR USD Index underlying the ETF ensures a diversified portfolio, with constituents selected based on their dividend-paying history and market capitalization.
Over the next three months, based on the current technical and fundamental data, EUNY is expected to maintain its stability, with potential price fluctuations within a narrow range. The ETF may experience slight volatility, driven by broader emerging market dynamics, but its low ATR suggests muted price swings. The 50-day moving average could act as a support level, while the 20-day moving average may present resistance. Investors can anticipate continued dividend income, with the potential for moderate capital appreciation aligned with the performance of the underlying index.
Additional Sources for EUNY ETF
EUNY ETF Overview
Market Cap in USD | 614m |
Category | Global Emerging Markets Equity |
TER | 0.65% |
IPO / Inception | 2011-11-25 |
EUNY ETF Ratings
Growth 5y | 45.3% |
Fundamental | - |
Dividend | 69.7% |
Rel. Strength Industry | -10.3 |
Analysts | - |
Fair Price Momentum | 15.51 EUR |
Fair Price DCF | - |
EUNY Dividends
Dividend Yield 12m | 8.20% |
Yield on Cost 5y | 12.16% |
Annual Growth 5y | 3.53% |
Payout Consistency | 93.4% |
EUNY Growth Ratios
Growth Correlation 3m | 34.5% |
Growth Correlation 12m | 79% |
Growth Correlation 5y | 37.4% |
CAGR 5y | 8.67% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.44 |
Alpha | 7.81 |
Beta | 0.38 |
Volatility | 15.17% |
Current Volume | 76.7k |
Average Volume 20d | 57.6k |
As of March 14, 2025, the stock is trading at EUR 14.01 with a total of 76,744 shares traded.
Over the past week, the price has changed by +0.21%, over one month by -1.97%, over three months by -0.13% and over the past year by +11.92%.
Partly, yes. Based on ValueRay Analyses, iShares Emerging Market (XETRA:EUNY) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 45.33 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EUNY as of March 2025 is 15.51. This means that EUNY is currently undervalued and has a potential upside of +10.71% (Margin of Safety).
iShares Emerging Market has no consensus analysts rating.
According to ValueRays Forecast Model, EUNY iShares Emerging Market will be worth about 17 in March 2026. The stock is currently trading at 14.01. This means that the stock has a potential upside of +21.2%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17 | 21.2% |